Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSTL | GLUE | NVAX | ||
| Company | Castle Biosciences Inc | Monte Rosa Therapeutics Inc | Novavax Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.54 | 17.23 | 6.85 | ||
| High | 40.10 | 17.50 | 6.91 | ||
| Low | 38.38 | 16.78 | 6.77 | ||
| Latest | 38.64 | 17.41 | 6.91 | ||
| Change | -0.98 | +0.15 | +0.05 | ||
| % Change | -2.47% | +0.87% | +0.73% | ||
| Volume | 549,800 | 719,600 | 3,721,800 | ||
| 20-Day Average Volume | 445,295 | 925,895 | 3,952,440 | ||
| Previous Close | 39.62 | 17.26 | 6.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 36.75 | 14.97 | 6.84 | ||
| 20-Day Raw Stochastic | 75.68% | 96.16% | 49.31% | ||
| 20-Day Relative Strength | 72.16 | 72.82 | 43.87 | ||
| Weighted Alpha | +35.93 | +156.15 | -27.71 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 48% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.28% since 11/28/25 | +7.67% since 11/28/25 | -1.99% since 11/28/25 | ||
| Low | 38.38 on 12/05/25 | 15.21 on 12/03/25 | 6.56 on 12/02/25 | ||
| High | 40.54 on 12/04/25 | 17.63 on 12/04/25 | 6.92 on 12/01/25 | ||
| 1-Month | |||||
| %Chg | +15.10% since 11/05/25 | +41.43% since 11/05/25 | -10.14% since 11/05/25 | ||
| Low | 32.51 on 11/10/25 | 11.90 on 11/07/25 | 6.20 on 11/20/25 | ||
| High | 40.61 on 11/28/25 | 17.63 on 12/04/25 | 7.92 on 11/06/25 | ||
| 3-Month | |||||
| %Chg | +64.01% since 09/05/25 | +252.43% since 09/05/25 | -12.53% since 09/05/25 | ||
| Low | 21.28 on 09/15/25 | 4.79 on 09/10/25 | 6.20 on 11/20/25 | ||
| High | 40.61 on 11/28/25 | 17.63 on 12/04/25 | 9.75 on 10/03/25 | ||
| 6-Month | |||||
| %Chg | +127.03% since 06/05/25 | +276.84% since 06/05/25 | -1.14% since 06/05/25 | ||
| Low | 14.59 on 08/04/25 | 4.12 on 08/08/25 | 6.13 on 06/23/25 | ||
| High | 40.61 on 11/28/25 | 17.63 on 12/04/25 | 10.64 on 08/18/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,127,863 | 1,133,704 | 1,122,868 | ||
| Shares Outstanding, K | 29,189 | 65,118 | 162,499 | ||
| Annual Sales | 332,070,000 | 75,620,000 | 682,160,000 | ||
| Annual Net Income | 18,250,000 | -72,700,000 | -187,500,000 | ||
| Last Quarter Sales | 83,040,000 | 12,770,000 | 70,450,000 | ||
| Last Quarter Net Income | -500,000 | -27,080,000 | -202,380,000 | ||
| 60-Month Beta | 1.14 | 1.60 | 2.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/03/25 | -0.33 on 11/06/25 | -0.62 on 11/06/25 | ||
| Latest Earnings Date | 11/03/25 | 11/06/25 | 11/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 158.48 | 53.94 | 2.83 | ||